W17 (Sumatriptan succinate 25 mg)
Pill imprint W17 has been identified as Sumatriptan succinate 25 mg.
Sumatriptan is used in the treatment of cluster headaches; migraine; new daily persistent headache; cyclic vomiting syndrome and belongs to the drug class antimigraine agents. Risk cannot be ruled out during pregnancy. Sumatriptan 25 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Imprint:
- W17
- Strength:
- 25 mg
- Color:
- White
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Antimigraine agents
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Hikma Pharmaceutical
More about sumatriptan
Consumer resources
- Sumatriptan
- Sumatriptan spray
- Sumatriptan tablets
- Sumatriptan injection
- Sumatriptan oral/nasal
- More (5) »
- Other brands: Imitrex, Zecuity, Onzetra Xsail, Imitrex Nasal, More (4) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
